Picture of GMP Insiders Expert Team

GMP Insiders Expert Team

The GMP Insiders Expert Team is a group of seasoned professionals specializing in quality assurance, regulatory compliance, and operational innovation in pharmaceutical and biotech manufacturing. United by a passion for advancing Good Manufacturing Practices, they transform complex compliance challenges into clear, actionable strategies that drive operational excellence.

Author social media channels:

Author's Latest Publications

FDA revises Preapproval Inspection (PAI) Compliance Program 7346.832, featured image showing regulatory documents and inspection records representing FDA risk-based pharmaceutical inspections.

FDA Rewrites Its Preapproval Inspection Playbook: Revised Compliance Program 7346.832

FDA's revised Compliance Program 7346.832 changes how Preapproval Inspections (PAIs) are planned, scoped, and conducted using a more risk-based inspection...
Revised EU GMP Annex 19 published, with a regulatory document being stamped and the subtitle on reference and retention samples before September 2026.

Revised EU GMP Annex 19: What Changes for Reference and Retention Samples?

The 2026 revision of EU GMP Annex 19 introduces focused updates for reference and retention samples, mainly affecting parallel trade,...
Featured image for an article on Quality Risk Management (QRM) in the pharmaceutical industry under ICH Q9(R1), showing the risk management cycle with risk identification, assessment, treatment, and monitoring.

Quality Risk Management in the Pharmaceutical Industry: From ICH Q9(R1) to Daily GMP Practice

Learn how Quality Risk Management under ICH Q9(R1) supports risk-based GMP decisions, inspection readiness, risk control, and pharmaceutical quality....
Pass box installed in a GMP cleanroom facility illustrating material transfer interface between controlled areas.

Types of Pass-boxes Used in GMP: Static, Dynamic, and Specialized Transfer Solutions

Learn the main types of pass boxes used in GMP facilities, including static, dynamic, and specialized units for controlled material...

Draft USP–NF PF 52(3): Proposed Updates to Glass Container and Solubility General Chapters

USP’s PF 52(3) drafts propose important updates to glass container chapters 〈660〉 and 〈1660〉, including new glass families, modernized identification...
Technician operating equipment in an ISO 7 cleanroom during contamination-sensitive manufacturing.

What Does ISO 7 Cleanroom Classification Mean?

A practical guide to ISO 7 cleanrooms in pharmaceutical manufacturing, covering classification, HVAC, monitoring, material flow, gowning, and cleaning....
Featured image for Pharmeuropa 38.2 draft updates showing regulatory documents and GMP Insiders branding.

Pharmeuropa 38.2: New Drafts Released for Public Consultation

Pharmeuropa 38.2 introduces draft revisions to bacterial endotoxin testing, particle-size analysis, and sieve chapters, with comments open until 30 June...
GMP Insiders feature image for an article on FDA final Q3 guidance for topical ANDAs, showing a stack of regulatory documents beside the headline text.

FDA Issues Final Guidance on Q3 Characterization of Topical Drug Products in ANDAs

FDA’s final Q3 guidance for topical ANDAs clarifies how physicochemical and structural characterization supports dosage form assessment and bioequivalence....
Draft USP–NF-PF-52(2)

Draft USP–NF PF 52(2): Proposed Updates to Sterilization and Analytical General Chapters

USP–NF PF 52(2) proposes updates to sterilization chapters, sterile filtration, particulate testing, analytical sieving, and melting point standards....
fda-warning-letter-analysis

FDA Warning Letter Analysis: Novo Nordisk Inc. and Failures in 15-Day Alert Reporting

FDA Warning Letter analysis of Novo Nordisk’s PADE violations, including missed 15-day Alert reports, weak ADE investigations, vendor oversight gaps,...

BECOME A GMP INSIDER

Stay in touch and be the first to get the latest GMP News!